Holmes, Ross P.
Ross P. Holmes
VIAF ID: 279414012 (Personal)
Permalink: http://viaf.org/viaf/279414012
Preferred Forms
- 100 1 _ ‡a Holmes, Ross P. (sparse)
-
- 100 1 0 ‡a Holmes, Ross P.
-
-
- 100 1 _ ‡a Holmes, Ross P.
- 100 1 _ ‡a Holmes, Ross P.
-
- 100 0 _ ‡a Ross P. Holmes
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
25-Hydroxysterols increase the permeability of liposomes to Ca2+ and other cations | |
Active site and loop 4 movements within human glycolate oxidase: implications for substrate specificity and drug design | |
Altered neutrophil permeability following shock wave exposure in vitro | |
The analysis of 25-hydroxycholesterol in plasma and cholesterol-containing foods by high-performance liquid chromatography | |
Biomembranes and cell function, 1983: | |
Calcium uptake during mitosis in the myxomycete Physarum polycephalum | |
The combined effects of shock waves and cisplatin therapy on rat prostate tumors | |
A comparison of the effects of cholesterol and 25-hydroxycholesterol on egg yolk lecithin liposomes: spin label studies | |
The effect of membrane lipid composition on the permeability of membranes to Ca2+. | |
Effect of soda consumption on urinary stone risk parameters | |
Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay. | |
The effects of (L)-2-oxothiazolidine-4-carboxylate on urinary oxalate excretion | |
The effects of Oxazyme on oxalate degradation: results and implications of in vitro experiments. | |
Failure of phosphatidic acid to translocate Ca2+ across phosphatidylcholine membranes | |
Fish oil supplementation and urinary oxalate excretion in normal subjects on a low-oxalate diet. | |
The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II | |
Genetic and dietary factors in urinary citrate excretion. | |
The genetic composition of Oxalobacter formigenes and its relationship to colonization and calcium oxalate stone disease | |
Glycolate and 2-phosphoglycolate content of tissues measured by ion chromatography coupled to mass spectrometry. | |
Glyoxylate reductase activity in blood mononuclear cells and the diagnosis of primary hyperoxaluria type 2 | |
Glyoxylate synthesis, and its modulation and influence on oxalate synthesis | |
Guaifenesin- and ephedrine-induced stones | |
The impact of dietary oxalate on kidney stone formation. | |
The influence of dietary isomeric and saturated fatty acids on atherosclerosis and eicosanoid synthesis in swine | |
Intestinal and renal handling of oxalate loads in normal individuals and stone formers. | |
Intravenous ascorbic acid infusions and oxalate production. | |
An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria | |
Irreversible inhibition of water transport in erythrocytes by fluoresceinmercuric acetate | |
The L530R variation associated with recurrent kidney stones impairs the structure and function of TRPV5. | |
A lack of coordination in the release of urinary lysosomal and brush border enzymes following renovascular surgery | |
Lowering urinary oxalate excretion to decrease calcium oxalate stone disease | |
Metabolism of primed, constant infusions of [1,2-¹³C₂] glycine and [1-¹³C₁] phenylalanine to urinary oxalate | |
Molecular Modeling of the Structural and Dynamical Changes in Calcium Channel TRPV5 Induced by the African-Specific A563T Variation | |
A mutation creating an out-of-frame alternative translation initiation site in the GRHPR 5'UTR causing primary hyperoxaluria type II. | |
Noncitrus alkaline fruit: a dietary alternative for the treatment of hypocitraturic stone formers | |
Oral antibiotic treatment of Helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes | |
Oxalate and sucralose absorption in idiopathic calcium oxalate stone formers | |
Oxalate Concentrations in Human Gastrointestinal Fluid. | |
Oxalate Formation From Glyoxal in Erythrocytes. | |
Oxalate induces mitochondrial dysfunction and disrupts redox homeostasis in a human monocyte derived cell line. | |
Oxalobacter colonization in the morbidly obese and correlation with urinary stone risk | |
Oxalobacter formigenes and its potential role in human health. | |
Proline dehydrogenase 2 (PRODH2) is a hydroxyproline dehydrogenase (HYPDH) and molecular target for treating primary hyperoxaluria | |
Quantitative assessment of citric acid in lemon juice, lime juice, and commercially-available fruit juice products | |
Relationship of protein intake to urinary oxalate and glycolate excretion | |
Reply: To PMID 25102784 | |
RNA interference in the treatment of renal stone disease: Current status and future potentials. | |
The role of renal water channels in health and disease. | |
The saturation and isomerization of dietary fatty acids and the respiratory properties of rat heart mitochondria | |
Selective elevation of urinary enzyme levels after extracorporeal shock wave lithotripsy | |
Sensitivity of human strains of Oxalobacter formigenes to commonly prescribed antibiotics. | |
Steatorrhea and Hyperoxaluria in Severely Obese Patients Before and After Roux-en-Y Gastric Bypass | |
Structural and biochemical studies of human 4-hydroxy-2-oxoglutarate aldolase: implications for hydroxyproline metabolism in primary hyperoxaluria | |
Tetrodotoxin protects against acute ischemic renal failure in the rat | |
Variability in urinary oxalate measurements between six international laboratories. |